HALOPERIDOL AND REDUCED HALOPERIDOL CONCENTRATIONS IN PLASMA AND RED BLOOD-CELLS FROM CHRONIC-SCHIZOPHRENIC PATIENTS

被引：0
|
作者：
KO, GN
KORPI, ER
KIRCH, DG
机构：
[1] ST ELIZABETHS HOSP,NIMH,NEUROPSYCHIAT BRANCH,WASHINGTON,DC 20032
[2] CUNY MT SINAI SCH MED,NEW YORK,NY 10029
[3] ALKO,FINNISH STATE ALCOHOL CO,RES LABS,HELSINKI,FINLAND
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1989年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：186 / 190
页数：5
相关论文
共 50 条
  • [21] Reduced haloperidol and haloperidol-pyridinium metabolites in schizophrenic patients
    Ulrich, S
    Meyer, FP
    PSYCHOPHARMAKOTHERAPIE, 1999, 6 (03): : 100 - 102
  • [22] EFFECTS OF SMOKING ON HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-CONCENTRATIONS AND HALOPERIDOL CLEARANCE
    JANN, MW
    SAKLAD, SR
    ERESHEFSKY, L
    RICHARDS, AL
    HARRINGTON, CA
    DAVIS, CM
    PSYCHOPHARMACOLOGY, 1986, 90 (04) : 468 - 470
  • [23] PHARMACOCLINICAL, CORRELATIONS IN SCHIZOPHRENIC-PATIENTS TREATED WITH HALOPERIDOL DECANOATE - CLINICAL-EVALUATIONS, CONCENTRATIONS OF PLASMA AND RED-BLOOD-CELL HALOPERIDOL AND ITS REDUCED METABOLITE, AND PLASMA HOMOVANILLIC-ACID
    AYMARD, N
    VIALA, A
    STEIN, I
    CAROLI, F
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1995, 19 (07): : 1119 - 1135
  • [24] HALOPERIDOL AND REDUCED HALOPERIDOL CONCENTRATIONS AND PSYCHIATRIC RATINGS IN SCHIZOPHRENIC-PATIENTS TREATED WITH ASCORBIC-ACID
    STRAW, GM
    BIGELOW, LB
    KIRCH, DG
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1989, 9 (02) : 130 - 132
  • [25] Haloperidol and reduced haloperidol plasma concentrations after a loading dose regimen with haloperidol decanoate
    Jann, MW
    Wei, FC
    Lin, HN
    Ching, PC
    Chang, WH
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1996, 20 (01): : 73 - 86
  • [26] VARIABILITY IN DECLINING HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-CONCENTRATIONS UPON HALOPERIDOL CESSATION
    LIN, SK
    CHANG, WH
    LAM, YWF
    JANN, MW
    DRUG INVESTIGATION, 1993, 5 (01): : 57 - 62
  • [27] REVERSIBLE METABOLISM OF HALOPERIDOL AND REDUCED HALOPERIDOL IN CHINESE SCHIZOPHRENIC-PATIENTS
    JANN, MW
    LAM, YWF
    CHANG, WH
    PSYCHOPHARMACOLOGY, 1990, 101 (01) : 107 - 111
  • [28] HALOPERIDOL REDUCTASE-ACTIVITY IN RED-BLOOD-CELLS FROM ORIENTAL PATIENTS ON HALOPERIDOL
    SOMEYA, T
    SHIBASAKI, M
    KATO, T
    NOGUCHI, T
    ISHIDA, N
    TAKAHASHI, S
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1991, 15 (02): : 275 - 278
  • [29] A CLINICAL-TRIAL COMPARING INTRAMUSCULAR HALOPERIDOL DECANOATE AND ORAL HALOPERIDOL IN CHRONIC-SCHIZOPHRENIC PATIENTS - EFFICACY, SAFETY, AND DOSAGE EQUIVALENCE
    NAIR, NPV
    SURANYICADOTTE, B
    SCHWARTZ, G
    THAVUNDAYIL, JX
    ACHIM, A
    LIZONDO, E
    NAYAK, R
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1986, 6 (01) : S30 - S37
  • [30] Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients
    Suzuki, A
    Otani, K
    Mihara, K
    Yasui, N
    Kaneko, S
    Inoue, Y
    Hayashi, K
    PHARMACOGENETICS, 1997, 7 (05): : 415 - 418
12345